M4C Nutraceutical Intervention Human Health Effects Pilot
Launched by CONCORDIA UNIVERSITY WISCONSIN · Jun 24, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The M4C Nutraceutical Intervention Human Health Effects Pilot is a study designed to explore how specific nutritional supplements, called nutraceuticals, can impact overall health and wellness. The trial will specifically look at various aspects such as energy levels, mental health, weight management, and other health factors over a period of three months. Healthy adults aged 65 to 74 and 29 to 219 years old can participate, as long as they do not have certain health conditions, like blood disorders or severe allergies to the supplements being tested.
Participants will start by completing a health questionnaire and undergoing several tests to measure their health, including checking their blood and body composition. This initial assessment will be followed by similar evaluations each month for three months. The goal is to see how these nutritional supplements affect their health over time. It’s important to note that this study is in its early stages and is not yet recruiting participants, but it aims to gather useful information for future research on health and nutrition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy adults
- Exclusion Criteria:
- • amputation
- • blood clotting disorder
- • metal implants or implanted electrical device(s)
- • known acute or chronic illness; gastrointestinal, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension
- • inability to fast i.e. low blood sugar
- • pregnant or may be pregnant during the course of the study
- • amino acid metabolizing disorder i.e. phenylketonuria
- • severe edema
- • did not pass screening criteria as determined by MRI facility
- • allergies/intolerance to any nutraceutical ingredients: amino acids, vitamins, minerals, tapioca starch, sunflower lecithin, stevia, limes or fatty acids like docosahexaenoic acid
About Concordia University Wisconsin
Concordia University Wisconsin is a private, Lutheran-based institution dedicated to advancing health sciences through innovative research and education. As a clinical trial sponsor, the university leverages its strong academic framework and commitment to high ethical standards to conduct impactful research aimed at improving patient outcomes and advancing medical knowledge. With a focus on collaboration and community engagement, Concordia University Wisconsin fosters interdisciplinary partnerships that enhance the effectiveness and reach of its clinical studies, ultimately contributing to the betterment of healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tonya Bartoletti
Study Director
Concordia University of Wisconsin ORSP assistant director
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported